Repurposing old drugs as antiviral agents for coronaviruses

BACKGROUND: New therapeutic options to address the ongoing coronavirus disease 2019 (COVID-19) pandemic are urgently needed. One possible strategy is the repurposing of existing drugs approved for other indications as antiviral agents for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)....

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Cheng-Wei, Peng, Tzu-Ting, Hsu, Hsing-Yu, Lee, Yue-Zhi, Wu, Szu-Huei, Lin, Wen-Hsing, Ke, Yi-Yu, Hsu, Tsu-An, Yeh, Teng-Kuang, Huang, Wen-Zheng, Lin, Jiunn-Horng, Sytwu, Huey-Kang, Chen, Chiung-Tong, Lee, Shiow-Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chang Gung University 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245249/
https://www.ncbi.nlm.nih.gov/pubmed/32563698
http://dx.doi.org/10.1016/j.bj.2020.05.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245249/
https://www.ncbi.nlm.nih.gov/pubmed/32563698
http://dx.doi.org/10.1016/j.bj.2020.05.003

Ejemplares similares